Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview of septicemia.

M Venditti1, P Serra

  • 1Istituto di Clinica Medica VI, Università La Sapienza, Roma, Italy.

Journal of Chemotherapy (Florence, Italy)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Septicemia remains a significant medical challenge, with evolving causes like staphylococci in immunocompromised patients. Optimal management requires tailored antimicrobial strategies based on pathogen shifts and clinical context.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients.

International journal of antimicrobial agents·2024
Same author

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

Volumetric evaluations of the maxillary sinus before and post regenerative surgery.

European review for medical and pharmacological sciences·2023
Same author

Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations.

Journal of global antimicrobial resistance·2023
Same author

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort.

African journal of thoracic and critical care medicine·2023
Same author

Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing <i>Klebsiella pneumoniae</i>: results from a multicentre retrospective study.

JAC-antimicrobial resistance·2022

Area of Science:

  • Infectious Diseases
  • Internal Medicine
  • Clinical Microbiology

Background:

  • Septicemia continues to pose a significant threat in modern medicine, with clinical presentations and outcomes varying over time and across settings.
  • Historically, gram-negative bacilli were primary culprits in fulminant septicemia among granulocytopenic patients.
  • Contemporary factors such as indwelling central venous catheters and quinolone prophylaxis have shifted the causative agents towards coagulase-negative staphylococci in these patients.

Purpose of the Study:

  • To highlight the evolving landscape of septicemia pathogens and their clinical implications.
  • To underscore the need for adaptive management strategies in febrile episodes, particularly in granulocytopenic patients.
  • To discuss emerging clinical syndromes of infective endocarditis, including those associated with medical devices.

Related Experiment Videos

Main Methods:

  • Review of clinical observations and treatment outcomes in septicemia and infective endocarditis.
  • Analysis of shifts in prevalent pathogens causing septicemia in specific patient populations (e.g., granulocytopenic patients, intravenous drug users).
  • Examination of the role of medical devices and prophylactic treatments in the epidemiology of septicemia.

Main Results:

  • Coagulase-negative staphylococci have emerged as a major cause of septicemia in granulocytopenic patients, supplanting gram-negative bacilli in some contexts.
  • Right-sided infective endocarditis is increasingly associated with intravenous drug use and infections of indwelling devices.
  • Optimal management for febrile granulocytopenic patients necessitates broad-spectrum antibiotics initially, with consideration for antistaphylococcal agents if no improvement occurs within 72 hours.

Conclusions:

  • The management of septicemia requires continuous adaptation to changing etiological patterns.
  • Antistaphylococcal coverage should be incorporated into treatment protocols for febrile granulocytopenic patients not responding to initial broad-spectrum therapy.
  • Physicians must remain vigilant for novel presentations of infective endocarditis, particularly those linked to healthcare-associated infections and device use.